Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 21 466 M
EBIT 2015 9 101 M
Net income 2015 2 656 M
Debt 2015 39 628 M
Yield 2015 0,01%
Sales 2016 24 620 M
EBIT 2016 11 643 M
Net income 2016 5 088 M
Debt 2016 31 819 M
Yield 2016 0,01%
PER 2015 37,28
PER 2016 23,48
EV / Sales 2015 7,39x
EV / Sales 2016 6,13x
Capitalization 119 091 M
More Financials
Company
Allergan Plc operates as an investment holding company.It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products.The company operates through the following segments: North... 
Sector
Pharmaceuticals
Calendar
07/23Earnings Release
More about the company
Surperformance© ratings of Actavis Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACTAVIS INC
06/30DJTOWERS WATSON : Lower Taxes Not Main Driver of Willis Deal
06/30DJTOWERS WATSON : Lower Taxes Not Main Driver of Willis Deal
06/25 CANADA'S VALEANT APPROACHES TO BUY Z : Wsj
06/25DJELI LILLY : Wins Alimta Patent Case in U.K.
06/25DJELI LILLY : Wins Alimta Patent Case in U.K.
06/25DJHow Much the Best-Performing and Worst-Performing CEOs Got Paid
06/24DJHow Much the Best-Performing and Worst-Performing CEOs Got Paid
06/23DJU.S. Stocks Edge Up; Nasdaq Ends at Record
More news
Sector news : Pharmaceuticals - NEC
08:34a NOVO NORDISK A/S : A/S : - Share repurchase programme
08:31a TEVA PHARMACEUTICAL : Launches Generic Aggrenox® Capsules in the United States
08:15a TEVA PHARMACEUTICAL : and Xenon Provide Update on TV-45070 Phase 2b Study in Ost..
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions